MONTREAL, Oct. 23 /CNW Telbec/ - A congratulatory luncheon was organized
today by BIOQuebec to pay tribute to Axcan Pharma for its 25th anniversary.
In front of over 150 guests, including many of Axcan's business partners,
Mr. Patrick Montpetit, BIOQuebec's Chairman of the Board, presented Axcan's
President and CEO, Dr. Frank Verwiel, with a commemorative plaque to salute
the 25 years of success this Quebec company has enjoyed.
Axcan Pharma is a pharmaceutical company specializing in the development
and marketing of prescription products to treat gastrointestinal diseases and
Founded in 1982 by Mr. Léon F. Gosselin, currently Chairman of the Board,
the company's mission is to offer patients and specialized caregivers
effective treatments and medications for conditions such as inflammatory bowel
disease, irritable bowel syndrome, cholestatic liver diseases and
complications due to pancreatic insufficiency.
Axcan's revenues have steadily increased since its foundation. In 2006,
Axcan reached 292 million USD in sales and, for 2007, revenues should reach
between 335 and 343 million USD. Results for 2007 will be announced at the end
During his speech, Dr. Verwiel, at the head of Axcan since 2005,
mentioned that: "Axcan rapidly found its place in a highly competitive market
and ensured its success with key partnerships that have proven very
For his part, Patrick Montpetit declared that: "For the pharmaceutical
industry to grow, it is primordial to ensure that local successes become
international leaders, as was the case with Axcan".
BIOQuebec is Quebec's Bio-Industries and Life Sciences Business Network.
Over 240 companies, organizations and R & D labs make up its membership. The
association works to create a positive influence on the growth of the life
science industry, including capital access, public policy, workforce
development and international promotion.
For further information:
For further information: Mathieu Vidal, Directeur aux communications et
aux événements, BIOQuébec, (514) 733-8411 - poste 204, www.bioquebec.com